BASF invests 15 million euros to increase production capacity in Brazil and expand the supply of Mefentrifluconazole in Latin America

At the end of 2023, BASF announced an investment of approximately €15 million in a new plant and infrastructure in Brazil, covering 400 square meters, with a view to increasing the production capacity of its global focus product Revysol (active ingredient: Mefentrifluconazole), in order to further expand Revysol's presence in the agricultural market in Brazil and throughout Latin America.

BASF said the investment aims to increase its annual production capacity by 45 percent to ensure greater agility, flexibility and security in the delivery of crop protection solutions.

Mefentrifluconazole is a new triazole fungicide developed by BASF, which was first launched in South Korea in 2018 and is now available in Korea, Colombia, 24 member states of the European Union, the United States, Canada, the United Kingdom, Australia, New Zealand, China and other countries. The main products mixed with Mefentrifluconazole are Pyraclostrobin and Fluxapyroxad. The main dosage forms registered include: EC, SC, FS, etc. Its annual peak sales are expected to exceed €1bn.

Basf's recent offerings in the Brazilian market include: 

In January 2022, the active ingredient Mefentrifluconazole was registered for the first time in Brazil for the control of diseases such as Ramularia and soybean rust. 

In September 2022, BASF launched Belyan (Mefentrifluconazole 133.3 g/L+ Fluxapyroxad 88.9 g/L+ Pyraclostrobin 177.8 g/L) for soybean and cotton crops in Brazil, which is one of the important products launched by the company globally in recent years.